Chinese pharma company’s licence cancelled over inspection
August 30th, 2011 - 10:07 pm ICT by IANSNew Delhi, Aug 30 (IANS) India has cancelled the import licence granted to a Chinese pharma company after it refused to allow an Indian team to inspect the facility, Health Minister Ghulam Nabi Azad said Tuesday.
Azad said Chongqing Daxin Pharmaceutical Limited in Chongqing in China refused the visiting Indian inspecting team of the Central Drugs Standard Control Organisation (CDSCO) officials to inspect their facility.
According to Azad, the company said they have stopped manufacturing some of the registered drugs and are not in a position to export other drugs to India.
“The registration certificate and import licenses granted in favour of the firm were, therefore, cancelled in June 2011,” he told the Rajya Sabha.
The CDSCO lays down standards of drugs, cosmetics, diagnostics and devices in the country and also regulates market authorization of new drugs, approves drug formulations for manufacture and regulates clinical research in India.
- Panel to look into irregularities in drug trials - May 11, 2012
- Just 66 drug inspectors for 1.2 billion people in India - Aug 24, 2011
- Task force to look into pharma industry's problems: Azad - Sep 04, 2010
- Regulate foreign investment for cheaper medicines: Azad - Nov 01, 2010
- 85 shops found selling prohibited drugs - Jun 17, 2011
- Ulterior motives could be behind superbug claim: India - Aug 13, 2010
- India, Sweden to collaborate in health sector - Feb 20, 2012
- Foreign investment in pharma to face competition check - Oct 11, 2011
- 22 people died during clinical trials - Aug 09, 2011
- Ranbaxy launches 'indigenous' malaria drug - Apr 25, 2012
- Nearly 2,000 doctors named for taking pharma firms' gifts - Apr 23, 2010
- Proposal for free medicines at government facilities - Mar 20, 2012
- Pharmacists can bridge healthcare gap: Azad - Jul 09, 2010
- Stem cell division to evaluate clinical trials - Apr 27, 2012
- No EU blanket ban on ayurvedic medicines: Azad - Aug 02, 2011
Tags: cdsco, china, clinical research, control organisation, cosmetics, drug formulations, favour, ghulam nabi azad, health minister, import licenses, India, New Delhi, new drugs, pharma company, rajya sabha, registration certificate